๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Magnetic resonance imaging of the muscles in patients with polymyositis and dermatomyositis

โœ Scribed by MD Hiroyuki Fujino; MD Takuro Kobayashi; MD Ikuo Goto; MD Hideo Onitsuka


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
427 KB
Volume
14
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Magnetic resonance imaging (MRI) of the muscles was performed in patients with polymyositis and dermatomyositis. Lesions with high intensity on TPweighted image, but normal intensity on T I -weighted image, were observed in 7 of 8 patients in the active stage of the disease. Following clinical improvement with corticosteroid therapy in 4 patients, the high intensity lesions reverted to normal. The high intensity lesions seen on T2-weighted image in the active stage may represent edema and inflammation of the muscle. MRI of the muscle may serve as a diagnostic tool and be useful for follow-up of the patients with polymyositis or dermatomyositis.


๐Ÿ“œ SIMILAR VOLUMES


Magnetic resonance imaging of skeletal m
โœ Junko Fujitake; Yasuhiro Ishikawa; Hayato Fujii; Kazumasa Nishimura; Katsumi Hay ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 202 KB ๐Ÿ‘ 3 views

Magnetic resonance imaging of skeletal muscles was performed in 11 patients with polymyositis. Two types of muscle lesions were revealed. The first, inflammation, showed increased signal intensity on T2weighted images and iso-intensity on T1-weighted images. The second, fatty replacement, showed inc

Frequency of relapses in patients with p
โœ Beverley A. Phillips; Paul Zilko; Michael J. Garlepp; Frank L. Mastaglia ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 114 KB ๐Ÿ‘ 1 views

The frequency of clinical and biochemical relapses was determined in a group of 50 patients with polymyositis (PM), dermatomyositis (DM), or overlap syndromes who were followed for periods of up to 13 years. Relapses occurred in 30 of the 50 patients (60%) during the period of followup. The annual r